Quality key factors
Factor
Value
Sales Growth (5y)
28.20%
EBIT Growth (5y)
13.94%
EBIT to Interest (avg)
0.93
Debt to EBITDA (avg)
0.32
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
0.99
Tax Ratio
25.28%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.81%
ROE (avg)
8.26%
Valuation Key Factors 
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
1.94
EV to EBIT
15.47
EV to EBITDA
7.05
EV to Capital Employed
2.04
EV to Sales
1.10
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
12.46%
ROE (Latest)
5.20%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Bullish
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Kolinpharma SpA
Operating Cash Flow
Highest at EUR 5.46 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (EUR MM)
Net Sales
Highest at EUR 8.32 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (EUR MM)
Net Sales
At EUR 8.32 MM has Grown at 37.32%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (EUR MM)
Pre-Tax Profit
At EUR 0.71 MM has Grown at 76.89%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (EUR MM)
Net Profit
At EUR 0.46 MM has Grown at 56.15%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (EUR MM)
Debt-Equity Ratio
Lowest at -9.16 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 9.36%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 3.02%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Kolinpharma SpA
Raw Material Cost
Grown by 27.25% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






